Literature DB >> 21049102

Amino acids attached to 2'-amino-LNA: synthesis and excellent duplex stability.

Marie W Johannsen1, Lia Crispino, Michael C Wamberg, Neerja Kalra, Jesper Wengel.   

Abstract

The synthesis of 2'-amino-LNA (the 2'-amino derivative of locked nucleic acid) has opened up a number of exciting possibilities with respect to modified nucleic acids. While maintaining the excellent duplex stability inferred by LNA-type oligonucleotides, the nitrogen in the 2'-position of 2'-amino-LNA monomers provides an excellent handle for functionalisation. Herein, the synthesis of amino acid functionalised 2'-amino-LNA derivatives is described. Following ON synthesis, a glycyl unit attached to the N2'-position of 2'-amino-LNA monomers was further acylated with a variety of amino acids. On binding to DNA/RNA complements, the modified ONs induce a marked increase in thermal stability, which is particularly apparent in a buffer system with a low salt concentration. The increase in thermal stability is thought to be caused, at least in part, by decreased electrostatic repulsion between the negatively charged phosphate backbones when positively charged amino acid residues are appended. Upon incorporation of more than one 2'-amino-LNA modification, the effects are found to be nearly additive. For comparison, 2'-amino-LNA derivatives modified with uncharged groups have been synthesised and their effect on duplex thermal stability likewise investigated.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21049102     DOI: 10.1039/c0ob00532k

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  6 in total

1.  Fatty Acid-Modified Gapmer Antisense Oligonucleotide and Serum Albumin Constructs for Pharmacokinetic Modulation.

Authors:  Michael Lykke Hvam; Yunpeng Cai; Frederik Dagnæs-Hansen; Jesper Sejrup Nielsen; Jesper Wengel; Jørgen Kjems; Kenneth A Howard
Journal:  Mol Ther       Date:  2017-06-20       Impact factor: 11.454

2.  Next-generation bis-locked nucleic acids with stacking linker and 2'-glycylamino-LNA show enhanced DNA invasion into supercoiled duplexes.

Authors:  Sylvain Geny; Pedro M D Moreno; Tomasz Krzywkowski; Olof Gissberg; Nicolai K Andersen; Abdirisaq J Isse; Amro M El-Madani; Chenguang Lou; Y Vladimir Pabon; Brooke A Anderson; Eman M Zaghloul; Rula Zain; Patrick J Hrdlicka; Per T Jørgensen; Mats Nilsson; Karin E Lundin; Erik B Pedersen; Jesper Wengel; C I Edvard Smith
Journal:  Nucleic Acids Res       Date:  2016-02-08       Impact factor: 16.971

3.  CTG repeat-targeting oligonucleotides for down-regulating Huntingtin expression.

Authors:  Eman M Zaghloul; Olof Gissberg; Pedro M D Moreno; Lee Siggens; Mattias Hällbrink; Anna S Jørgensen; Karl Ekwall; Rula Zain; Jesper Wengel; Karin E Lundin; C I Edvard Smith
Journal:  Nucleic Acids Res       Date:  2017-05-19       Impact factor: 16.971

4.  A self-assembled, modular nucleic acid-based nanoscaffold for multivalent theranostic medicine.

Authors:  Veronica Liv Andersen; Mathias Vinther; Rajesh Kumar; Annika Ries; Jesper Wengel; Jesper Sejrup Nielsen; Jørgen Kjems
Journal:  Theranostics       Date:  2019-04-13       Impact factor: 11.556

5.  Splice-correcting oligonucleotides restore BTK function in X-linked agammaglobulinemia model.

Authors:  Burcu Bestas; Pedro M D Moreno; K Emelie M Blomberg; Dara K Mohammad; Amer F Saleh; Tolga Sutlu; Joel Z Nordin; Peter Guterstam; Manuela O Gustafsson; Shabnam Kharazi; Barbara Piątosa; Thomas C Roberts; Mark A Behlke; Matthew J A Wood; Michael J Gait; Karin E Lundin; Samir El Andaloussi; Robert Månsson; Anna Berglöf; Jesper Wengel; C I Edvard Smith
Journal:  J Clin Invest       Date:  2014-08-08       Impact factor: 14.808

6.  Synthesis of Oligonucleotides Containing 2'-N-alkylaminocarbonyl-2'-amino-LNA (2'-urea-LNA) Moieties Using Post-Synthetic Modification Strategy.

Authors:  Shoko Yamashita; Kodai Nishida; Takashi Osawa; Ayumi Nakanishi; Yuta Ito; Yoshiyuki Hari
Journal:  Molecules       Date:  2020-01-15       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.